Possible mechanism of induction of benign prostatic hyperplasia by estradiol and dihydrotestosterone in dogs

Toxicology and Applied Pharmacology

Volumn 136, Issue 2, 1996, Pages 211-219

  Winter, Mark L ^a   Liehr, Joachim G ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHOXYCOUMARIN DEETHYLASE; ANDROSTANOLONE; CATALASE; ESTRADIOL; GLUTATHIONE PEROXIDASE; OXYGENASE; UNSPECIFIC MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; MALE; NONHUMAN; PROSTATE HYPERTROPHY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030047268     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0027     Document Type: Article

References (46)

1. Benson, A. M., Hunkeler, M. J., and Talalay, P. (1980). Increase of NAD(P)H:quinone reductase by dietary antioxidants: Possible role in protection against carcinogenesis and toxicity. Proc. Natl. Acad. Sci. USA 77, 5216-5220.
2. Berry, S. J., Coffey, D. S., Strandberg, J. D., and Ewing, L. L. (1986). Effect of age, castration, and testosterone replacement on the development and restoration of canine benign prostatic hyperplasia. Prostate 9, 295-302.
3. Bradford, M. M. (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
4. Claiborne, A. (1985). Catalase activity. In CRC Handbook of Methods for Oxygen Radical Research (R. A. Greenwald, Ed.), pp. 283-284. CRC Press, Boca Raton, FL.
5. Dignam, J. D., and Strobel, H. W. (1977). NADPH-cytochrome P-450 reductase from rat liver: Purification by affinity chromatography and characterization. Biochemistry 16, 1116-1123.
6. Ernster, L. (1967). DT diaphorase. Methods Enzymol. 10, 309-317.
7. Floyd, R. A., Watson, J. J., and Wong, P. K. (1986). Hydroxyl free radical adduct of deoxyguanosine: Sensitive detection and mechanisms of formation. Free Radical Res. Commun. 1, 163-172.
8. Gloyna, R. E., Siiteri, P. K., and Wilson, J. D. (1970). Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog. J. Clin. Invest. 49, 1746-1753.
9. Greenlee, W. F., and Poland, A. (1978). An improved assay of 7-ethoxycoumarin O-deethylase activity: Induction of hepatic activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Pharmacol. Exp. Ther. 205, 596-605.
10. Guengerich, F. P. (1989). Characterization of human microsomal cytochrome P450 enzymes. Annu. Rev. Pharmacol. Toxicol. 29, 241-264.
11. Guengerich, F. P., Dannan, G. A., Wright, S. T., Martin, M. V., and Kaminsky, L. S. (1982). Purification and characterization of microsomal cytochrome P-450s. Xenobiotica 12, 701-716.
12. Gupta, R. C. (1984). Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc. Natl. Acad. Sci. USA 81, 6943-6947.
13. Harris, E. D. (1992). Regulation of antioxidant enzymes. FASEB J. 6, 2675-2683.
14. Henderson, D., Habenicht, U.-F., Nishino, Y., and El Etreby, M. F. (1987). Estrogens and benign prostatic hyperplasia: The basis for aromatase inhibitor therapy. Steroids 50, 1-3.
15. Ho, S.-M., and Levin, V. (1986). Induction of progesterone receptors by androgens in the mouse uterus. Mol. Cell. Endocrinol. 46, 103-108.
16. Ho, S.-M., and Ofner, P. (1986). Prostatic cytosol binding of 5α-androstane-3β,17β-diol and estradiol-17β. Steroids 47, 21-33.
17. Ho, S.-M., and Roy, D. (1994). Sex hormone-induced nuclear DNA damage and lipid peroxidation in the dorsolateral prostates of Noble rats. Cancer Lett. 84, 155-162.
18. Huggins, C., and Clark, P. J. (1940). Quantitative studies of prostatic secretion. II. The effect of castration and of estrogen injections on the normal and on the hyperplastic prostate of dogs. J. Exp. Med. 72, 747-761.
19. Huggins, C., and Sommer, J. L. (1987). Quantitative studies of prostatic secretion. III. Simultaneous measurement of size and secretion of the canine prostate and the interaction of the canine prostate an the interaction of androgenic and estrogenic substances theron. J. Exp. Med. 97, 663-680.
20. Isaacs, J. T. (1984). Common characteristics of human and canine benign prostatic hyperplasia. In New Approaches to the Study of Benign Prostatic Hyperplasia (F. A. Kimball, A. E. Buhl, and D. E. Carter, Eds.), pp. 217-234. A. R. Liss, New York.
21. 3 steroid metabolites of 5α-androstane-3β,17β-diol produced by the canine prostate: 5α-Androstane-3β,6α,17β-triol and 5α-androstane-3β,7α,17β-triol. Steroids 35, 139-156.
22. Liehr, J. G., Ari-Ulubelen, A., and Strobel, H. W. (1987). Cytochrome P-450-mediated redox cycling of estrogens. J. Biol. Chem. 261, 16865-16870.
23. Liehr, J. G., and Roy, D. (1990). Free radical generation by redox cycling of estrogens. Free Radicals Biol. Med. 8, 415-423.
24. Liehr, J. G., Roy, D., Ari-Ulubelen, A., Bui, Q. D., Weisz, J., and Strobel, H. W. (1990). Effect of chronic estrogen treatment of Syrian hamsters on microsomal enzymes mediating formation of catechol estrogens and their redox cycling: Implications for carcinogenesis. J. Steroid Biochem. 35, 555-560.
25. Mohandas, J., Marshall, J. J., Duggin, G. G., Horvath, J. S., and Tiller, D. D. (1984). Differential distribution of glutathione and glutathione-related enzymes in rabbit kidney: Possible implications in analgesic nephropathy. Cancer Res. 44, 5086-5091.
26. 14C by the canine prostate and urinary blad-der in vivo. Endocrinology 87, 394.
27. Nebert, D. W., and Gelboin, H. V. (1968). Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. I. Assay and properties of induced enzyme. J. Biol. Chem. 243, 6242-6249.
28. Ofner, P., Bosland, M. C., and Vena, R. L. (1992). Differential effects of diethylstilbestrol and estradiol-17β in combination with testosterone on rat prostate lobes. Toxicol. Applied Pharmacol. 112, 300-309.
29. Ofner, P., Sousa, R. L., Vena, R. L., Krinsky-Feibush, P., and LeQuesne, P. W. (1983). Metabolism of radiotestosterone to 3β,6α-and 3β,7α-dihydroxy 5α-steroids by rat ventral, canine and human prostate in organ culture. J. Steroid Biochem. 18, 415-423.
30. 19-radiosteroids by expiants of canine prostate and epididymis with disposition as hydroxylated products: A possible mechanism for androgen inactivation. J. Steroid Biochem. 11, 1367-1379.
31. Oliver, C. N., Ahn, B., Moreman, E. J., Goldstein, S., and Stadtman, E. R. (1987). Age-related changes in oxidized proteins. J. Biol. Chem. 262, 5488-5491.
32. Omura, T., and Sato, R. (1964). The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239, 2370-2378.
33. Roy, D., Hachey, D., and Liehr, J. G. (1991). Determination of estradiol 2-and 4-hydroxylase activities by gas chromatography with electron-capture detection. J. Chromatogr. 567, 309-318.
34. Roy, D., and Liehr, J. G. (1988). Temporary decrease in renal quinone reductase activity induced by chronic administration of estradiol to male Syrian hamsters: Increased superoxide formation by redox cycling of estrogens. J. Biol. Chem. 263, 3646-3651.
35. Roy, D., and Liehr, J. G. (1989). Changes in activities of free radical detoxifying enzymes in kidneys of male Syrian hamsters treated with estradiol. Cancer Res. 49, 1475-1480.
36. Ryan, D. E., Iida, S., Wood, A. W., Thomas, P. E., Lieber, C. S., and Levin, W. (1984). Characterization of three highly purified cytochromes P-450 from hepatic microsomes of adult male rats. J. Biol. Chem. 259, 1239-1250.
37. SAS Institute Inc. (1988). SAS/STAT User's Guide, Release 6.03 ed., Cary, NC.
38. Sepkovic, D. W., Bradlow, H. L., Michnovicz, J., Murtezani, S., Levy, I., and Osborne, M. P. (1994). Catechol estrogen production in rat microsomes after treatment with indole-3-carbinol, ascorbigen, or β-naphthoflavone: A comparison of stable isotope dilution gas chromatography-mass spectrometry and radiometric methods. Steroids B59, 318-323.
39. Thayer, S. W. (1988). Evaluation of tissue indicators of oxidative stress in rats treated chronically with adriamycin. Biochem. Pharmacol. 37, 2189-2194.
40. Tomlinson, C. W., Godin, D. V., and Rabkin, S. W. (1981). Adriamycin cardiomyopathy: Implications of cellular changes in a canine model with mild impairment of left ventricular function. Biochem. Pharmacol. 34, 4033-4041.
41. Vincent, D. L., Kepic, T. A., and Falvo, R. E. (1979). Testosterone regulation of luteinizing hormone secretion in the male dog. Int. J. Androl. 2, 241-249.
42. Wade, D. R., Pirmann, J. C., Winter, M. L., and Falvo, R. E. (1981). A non-invasive technique for monitoring changes in prostatic size in vivo. Invest. Urol. 18, 266-269.
43. Walsh, P. C. (1984). Human benign prostatic hyperplasia: Etiological considerations. In New Approaches to the Study of Benign Prostatic Hyperplasia (F. A. Kimball, A. E. Buhl, and D. B. Carter, Eds.), pp. 1-25. A. R. Liss, New York.
44. Wenderth, U. K., George, F. Z. W., and Wilson, J. D. (1983). The effect of a 5α-reductase inhibitor on androgen mediated growth of the dog prostate. Endocrinology 113, 569-573.
45. Winter, M. L., Bosland, M. C., Wade, D. R., Falvo, R. E., Nagamani, M., and Liehr, J. G. (1995). Induction of benign prostatic hyperplasia in intact dogs by near-physiological levels of 5α-dihydrotestosterone and 17β-estradiol. Prostate 26, 325-333.
46. 3H]-hydride reduction. J. Biol. Chem. 266, 14446-14450.